In the past few months, court records show dozens of lawsuits filed by patients in Marion County against Indianapolis-based ...

This opens the door to making mistakes—ones that could worsen your side effects, affect how much weight you’ll lose, or even ...

Smith ⁠Drug asked the court for an unspecified amount of monetary damages on behalf of a proposed class of Victoza purchasers ...

Danish drugmaker Novo Nordisk faces a class action lawsuit in New York. The company is accused of using its patents to keep a ...

Scammers are taking advantage of the headline hype, according to the Better Business Bureau Serving Central Indiana.

GLP‑1 weight‑loss drugs are reshaping food industry demand, but side effects, cost barriers and unclear long‑term impacts ...

Adults with type 1 diabetes who used a GLP-1 receptor agonist or other incretin-based drug had lower risk for all-cause ...

This article was reviewed by Lynn Marie Morski, MD, JD Key Takeaways: Peptides are compounds made of amino acids linked by ...

New studies raise the possibility that GLP-1 medications beat aspirin in reducing colorectal cancer risk, and may improve outcomes for people who do develop the disease.

Novo Nordisk faces a class action lawsuit for allegedly monopolizing its diabetes drug Victoza through patent misuse and ...